Apex Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Apex Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$8.5M	Buy	97,561 +6,682	+7%	+$585K	0.19%	124
2015 Q4	$10.7M	Buy	90,879 +1,507	+2%	+$149K	0.24%	100
2015 Q3	$7.87M	Buy	89,372 +4,160	+5%	+$484K	0.18%	120
2015 Q2	$9.24M	Buy	85,212 +6,936	+9%	+$863K	0.2%	108
2015 Q1	$9.88M	Buy	78,276 +10,452	+15%	+$1.36M	0.23%	91
2014 Q4	$8.61M	Buy	67,824 +31,862	+89%	+$4.42M	0.23%	89
2014 Q3	$4.83M	Buy	+35,962	New	+$5.04M	0.15%	115

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Apex Capital Management's TNDM Position: Q1 2016 in Review

Apex Capital Management increased its Tandem Diabetes Care (TNDM) stake by 7.4% in Q1 2016, buying an estimated $585K and bringing the position to 97,561 shares worth $8.5M. The position accounts for 0.19% of the portfolio, ranked #124.

Apex Capital Management first reported a position in TNDM in Q3 2014 and has held it in 7 quarters since. The position peaked at $10.7M in Q4 2015. 90 funds tracked by Wall St. Rank hold TNDM as of Q1 2016.

Apex Capital Management held 97,561 shares of Tandem Diabetes Care worth $8.5M as of Q1 2016.
Apex Capital Management bought 6,682 Tandem Diabetes Care shares in Q1 2016, an estimated $585K.
Tandem Diabetes Care made up 0.19% of Apex Capital Management's portfolio in Q1 2016, its #124 holding.
Apex Capital Management first reported a position in Tandem Diabetes Care in Q3 2014 and has held it in 7 quarters since.
Apex Capital Management's Tandem Diabetes Care position peaked at $10.7M in Q4 2015.
90 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.